Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

12345678910

European Medicine Agency to review GSK's chronic hepatitis B treatment

27th Mar 2026 08:38

(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted for review its investigational chronic hepatitis B treatment, bepirovirsen. Read More

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

27th Mar 2026 07:56

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More

WINNERS & LOSERS: Next climbs; Ceres jumps on Centrica deal

26th Mar 2026 10:46

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

LONDON MARKET CLOSE: FTSE 100 climbs on Middle East peace deal hopes

25th Mar 2026 16:59

(Alliance News) - Stocks rallied on Wednesday, and oil prices cooled, on hopes for an end to the conflict in the Middle East despite Iran reportedly rejecting a peace plan proposed by the US. Read More

DIRECTOR DEALINGS: GSK, Smiths Group and Savills directors buys shares

24th Mar 2026 14:13

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News: Read More

GSK's lung cancer treatment secures "orphan drug" status in Japan

23rd Mar 2026 08:37

(Alliance News) - GSK PLC on Monday said Japanese health authorities had granted "orphan drug" status to its lung cancer treatment. Read More

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

23rd Mar 2026 07:59

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its restructuring, and Applied Nutrition reports strong interim growth while holding back on shareholder payouts. Read More

GSK hails US FDA approval of Lynavoy for cholestatic pruritis form

19th Mar 2026 12:20

(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration approved Lynavoy for the treatment of cholestatic pruritus in patients with primary biliary cholangitis. Read More

UK shareholder meetings calendar - next 7 days

18th Mar 2026 11:43

Read More

LONDON MARKET CLOSE: Stocks and pound rise; US rate call approaches

17th Mar 2026 17:05

(Alliance News) - Stock prices in London closed higher on Tuesday, as uncertainty surrounding the Middle East conflict continued. Read More

GSK RSV vaccine secures age indication expansion from US FDA

13th Mar 2026 11:02

(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has gained an age indication expansion from the US Food & Drug Administration. Read More

GSK and Alfasigma ink agreement for worldwide rights for linerixibat

9th Mar 2026 09:01

(Alliance News) - GSK PLC on Monday announced a global licence deal with Alfasigma Spa for the worldwide rights for linerixibat, an investigational treatment for cholestatic pruritus in primary biliary cholangitis. Read More

LONDON BRIEFING: Astra drug wins US review as oil surges above USD100

9th Mar 2026 08:02

(Alliance News) - AstraZeneca secures US priority review for Enhertu, GSK agrees linerixibat deal with Alfasigma, while AdvancedAdvT rules out M&C Saatchi bid. Read More

TRADING UPDATES: Rosebank fundraise; Surface Transforms loses GM deal

3rd Mar 2026 22:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: Price targets raised for BP and Shell

2nd Mar 2026 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

GSK moves towards clearance of two new drugs in China and Japan

26th Feb 2026 09:42

(Alliance News) - GSK PLC on Thursday reported positive regulatory momentum in Japan and China, where two of its drugs have been accepted for review. Read More

GSK buys Canadian biopharmaceutical firm 35Pharma for USD950 million

25th Feb 2026 09:30

(Alliance News) - GSK PLC on Wednesday said it has agreed to buy Canada-based clinical stage biopharmaceutical firm 35Pharma Inc for USD950 million in cash. Read More

LONDON MARKET OPEN: Stocks fall after latest tariff salvo

23rd Feb 2026 08:51

(Alliance News) - Stock prices in Europe moved lower in early dealings on Monday, with enthusiasm at the start of the week tempered by tariff uncertainty, as US President Donald Trump hit out at a Supreme Court ruling and announced new trade curbs. Read More

IN BRIEF: GSK non-executive director buys nearly GBP75,000 in shares

20th Feb 2026 15:50

GSK PLC - London-based pharmaceuticals company - Independent Non-Executive Director Wendy Becker buys 3,334 shares, at GBP22.19, worth GBP73,990, on Friday in London. Read More

LONDON BROKER RATINGS: Shore raises Sage, UBS raises St James's Place

20th Feb 2026 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

12345678910
FTSE 100 Latest
Value9,967.35
Change-4.82